Enhanced detection of clinically significant prostate cancer in targeted and non-targeted regions using BiopSee® MRI/ultrasound fusion biopsy
Fusion biopsy using the BiopSee<sup>®</sup> system achieved a high csPCa detection rate in targeted ROIs, especially for PI-RADS 4 and 5 lesions, while also highlighting the importance of combining systematic biopsy with targeted approaches because of the substantial proportion of csPCa detected in non-ROI regions.
Authors
- Ken Nakahara (ORCID: https://orcid.org/0000-0002-4992-7582)
Institutions
- Nihon University (JP)
Publication Details
- Journal
- American Journal of Clinical and Experimental Urology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/qoda6396
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00